MXPA02012904A - Nueva forma cristalina y de sal de ter-butilamina de perindopril, metodo de preparacion y composiciones farmaceuticas que contienen las mismas. - Google Patents

Nueva forma cristalina y de sal de ter-butilamina de perindopril, metodo de preparacion y composiciones farmaceuticas que contienen las mismas.

Info

Publication number
MXPA02012904A
MXPA02012904A MXPA02012904A MXPA02012904A MXPA02012904A MX PA02012904 A MXPA02012904 A MX PA02012904A MX PA02012904 A MXPA02012904 A MX PA02012904A MX PA02012904 A MXPA02012904 A MX PA02012904A MX PA02012904 A MXPA02012904 A MX PA02012904A
Authority
MX
Mexico
Prior art keywords
novel
preparation
pharmaceutical compositions
crystalline form
compositions containing
Prior art date
Application number
MXPA02012904A
Other languages
English (en)
Inventor
Bruno Pfeiffer
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8852170&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA02012904(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of MXPA02012904A publication Critical patent/MXPA02012904A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
MXPA02012904A 2000-07-06 2001-07-06 Nueva forma cristalina y de sal de ter-butilamina de perindopril, metodo de preparacion y composiciones farmaceuticas que contienen las mismas. MXPA02012904A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0008791A FR2811318B1 (fr) 2000-07-06 2000-07-06 Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
PCT/FR2001/002169 WO2001083439A2 (fr) 2000-07-06 2001-07-06 NOUVELLE FORME CRISTALLINE η DU SEL DE TERT-BUTYLAMINE DU PERINDOPRIL, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT

Publications (1)

Publication Number Publication Date
MXPA02012904A true MXPA02012904A (es) 2003-09-22

Family

ID=8852170

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012904A MXPA02012904A (es) 2000-07-06 2001-07-06 Nueva forma cristalina y de sal de ter-butilamina de perindopril, metodo de preparacion y composiciones farmaceuticas que contienen las mismas.

Country Status (36)

Country Link
US (2) US20030158121A1 (es)
EP (1) EP1296948B1 (es)
JP (2) JP3592296B2 (es)
KR (1) KR100513572B1 (es)
CN (1) CN1328258C (es)
AP (1) AP1452A (es)
AR (1) AR029570A1 (es)
AT (1) ATE249435T1 (es)
AU (2) AU7642001A (es)
BG (1) BG66239B1 (es)
BR (1) BR0112211A (es)
CA (1) CA2415447C (es)
CZ (1) CZ302022B6 (es)
DE (1) DE60100761T2 (es)
DK (1) DK1296948T3 (es)
EA (1) EA004275B1 (es)
EE (1) EE05286B1 (es)
ES (1) ES2206423T3 (es)
FR (1) FR2811318B1 (es)
GE (1) GEP20043362B (es)
HK (1) HK1058199A1 (es)
HR (1) HRP20030078B1 (es)
HU (1) HU228115B1 (es)
ME (1) ME01367B (es)
MX (1) MXPA02012904A (es)
NO (1) NO323445B1 (es)
NZ (1) NZ523311A (es)
OA (1) OA12306A (es)
PL (1) PL348491A1 (es)
PT (1) PT1296948E (es)
RS (1) RS51621B (es)
SI (1) SI1296948T1 (es)
SK (1) SK287452B6 (es)
UA (1) UA57187C2 (es)
WO (1) WO2001083439A2 (es)
ZA (1) ZA200300025B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2834893B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de perindopril
GB2395195A (en) * 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
ES2382171T3 (es) 2003-06-24 2012-06-06 Les Laboratoires Servier Nuevas formas cristalinas de perindopril erbumina
WO2005019173A1 (en) * 2003-08-21 2005-03-03 Hetero Drugs Limited Process for pure perindopril tert-butylamine salt
ATE452124T1 (de) 2003-10-21 2010-01-15 Servier Lab Verfahren zur herstellung kristallinem perindopril erbumin
SI21704A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd New crystal form of perindopril, procedure of its preparation, pharmaceutical preparations containing this form and their application in treatment of hypertensia
SI21703A (en) 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
HUE031058T2 (en) * 2004-03-29 2017-06-28 Servier Lab A method of producing a solid pharmaceutical composition
SI21800A (sl) 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
SG125975A1 (en) * 2005-03-11 2006-10-30 Servier Lab New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
SG125976A1 (en) * 2005-03-11 2006-10-30 Servier Lab New gama crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
JP2006290825A (ja) * 2005-04-13 2006-10-26 Shiono Chemical Co Ltd アルファ型ペリンドプリルエルブミンの製造法
WO2007017894A2 (en) * 2005-05-05 2007-02-15 Arch Pharmalabs Limited PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE
AU2006281681A1 (en) * 2005-08-12 2007-02-22 Sandoz Ag New crystalline form of perindopril erbumine
US20100016614A1 (en) * 2005-08-12 2010-01-21 Lek Pharmaceuticals D.D Process for the preparation of perindopril erbumine
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
WO2007092758A2 (en) * 2006-02-03 2007-08-16 Dr. Reddy's Laboratories Ltd. Crystalline forms of perindopril erbumine
FR2897866B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897865B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
EP2137148A1 (en) * 2007-03-22 2009-12-30 Aarti Healthcare Limited Process for the preparation of perindopril erbumine salt and novel polymorph (s) thereof
WO2008120241A2 (en) * 2007-03-29 2008-10-09 Ipca Laboratories Limited Novel alcohol solvates of perindopril erbumine
SI22543A (sl) * 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
PL2318365T3 (pl) * 2008-06-24 2016-02-29 Mylan Laboratories Ltd Nowe odmiany polimorficzne (L) argininianu peryndoprylu i sposoby ich wytwarzania
KR200453510Y1 (ko) * 2009-02-09 2011-05-11 윤유원 튀김유 정제기
KR101041878B1 (ko) * 2009-03-26 2011-06-15 신준호 튀김장치용 찌꺼기 제거장치
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
PT105315B (pt) 2010-09-29 2013-01-16 Inst Superior Tecnico Uma nova forma cristalina hidratada de erbumina de perindopril, métodos para a sua preparação e sua utilização em preparações farmacêuticas
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
FR2620703B1 (fr) * 1987-09-17 1991-10-04 Adir Procede de synthese industrielle de l'acide perhydroindole carboxylique - 2(2s, 3as, 7as). application a la synthese de carboxyalkyl dipeptides
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
EA004275B1 (ru) 2004-02-26
JP2003531890A (ja) 2003-10-28
JP2005002120A (ja) 2005-01-06
CA2415447A1 (fr) 2001-11-08
NO20030051D0 (no) 2003-01-06
EP1296948B1 (fr) 2003-09-10
DK1296948T3 (da) 2004-01-05
FR2811318B1 (fr) 2002-08-23
RS51621B (sr) 2011-08-31
GEP20043362B (en) 2004-06-10
OA12306A (en) 2003-12-23
SK1502003A3 (en) 2003-06-03
PL348491A1 (en) 2002-01-14
UA57187C2 (uk) 2003-06-16
CN1328258C (zh) 2007-07-25
NO20030051L (no) 2003-01-06
SI1296948T1 (en) 2003-12-31
PT1296948E (pt) 2003-12-31
US20040248817A1 (en) 2004-12-09
WO2001083439A2 (fr) 2001-11-08
HK1058199A1 (en) 2004-05-07
CZ2003358A3 (cs) 2003-05-14
JP3592296B2 (ja) 2004-11-24
EA200300104A1 (ru) 2003-06-26
AP2002002709A0 (en) 2002-12-31
AU7642001A (en) 2001-11-12
YU100302A (sh) 2003-08-29
EE05286B1 (et) 2010-04-15
CZ302022B6 (cs) 2010-09-08
NZ523311A (en) 2004-06-25
HUP0102814A2 (hu) 2002-02-28
BG107534A (bg) 2003-12-31
WO2001083439A3 (fr) 2002-02-07
KR20030024774A (ko) 2003-03-26
JP5016184B2 (ja) 2012-09-05
ATE249435T1 (de) 2003-09-15
HUP0102814A3 (en) 2003-12-29
HRP20030078B1 (en) 2004-06-30
FR2811318A1 (fr) 2002-01-11
ME01367B (me) 2013-12-20
CN1440386A (zh) 2003-09-03
NO323445B1 (no) 2007-05-07
CA2415447C (fr) 2008-12-09
KR100513572B1 (ko) 2005-09-09
DE60100761T2 (de) 2004-07-15
EE200300003A (et) 2004-08-16
ES2206423T3 (es) 2004-05-16
HU0102814D0 (en) 2001-09-28
AU2001276420B2 (en) 2006-11-16
HU228115B1 (hu) 2012-11-28
ZA200300025B (en) 2004-02-10
US20030158121A1 (en) 2003-08-21
EP1296948A2 (fr) 2003-04-02
BG66239B1 (bg) 2012-08-31
AR029570A1 (es) 2003-07-02
DE60100761D1 (de) 2003-10-16
HRP20030078A2 (en) 2003-04-30
AP1452A (en) 2005-07-11
SK287452B6 (sk) 2010-10-07
BR0112211A (pt) 2003-05-06

Similar Documents

Publication Publication Date Title
AU7642001A (en) Novel $G(Y) crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
AU2001276420A1 (en) Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
AU7641901A (en) Novel dollar G(B crystalline form of perindopril tert- butylamine salt, preparation method, and pharmaceutical compositions containing same
AU2001276419A1 (en) Novel beta crystalline form of perindopril tert- butylamine salt, preparation method and pharmaceutical compositions containing same
ZA200210092B (en) alpha crystalline form of perindopril tert-butylamine salt.
HUP0400989A3 (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0301351A3 (en) Use of substituted dipeptides as growth hormone secretagogues, process for their preparation and pharmaceutical compositions containing them
IL150539A0 (en) Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them
HUP0300148A3 (en) Dipeptide nitrile cathepsin k inhibitors, process for their preparation and pharmaceutical compositions containing them
HU0103063D0 (en) New 2h-pyridazin-3-one derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0401141A3 (en) Crystalline forms of fluvastatin sodium, process for their preparation and pharmaceutical compositions containing them
HUP0303118A3 (en) Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
HUP0303270A3 (en) Isoxazoline derivatives as anti-depressants, process for their preparation and pharmaceutical compositions containing them
HUP0303361A3 (en) Substituted 1-aminobutan-3-ol derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0204001A3 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0401082A3 (en) Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them
SI1245565T1 (en) Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0400207A3 (en) Substituted 4-aminocyclohexanol derivatives, process for their preparation and pharmaceutical compositions containing them
SI1241169T1 (en) Isoindoloindolone derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0402283A3 (en) Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine, process for their preparation and pharmaceutical compositions containing them
HUP0101503A3 (en) Heterocycloalkyl- and heteroaryl-benzocyclobutane derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0102815A3 (en) New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it
HUP0101504A3 (en) New cyclobutaindolecarboxamide derivatives, process for their preparation and pharmaceutical compositions containing them
SI1266887T1 (sl) Derivati indenoindolona, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo
HUP0303482A3 (en) Mercaptoacetylamide derivatives, process for their preparation and their use and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FG Grant or registration